iberdomide   Click here for help

GtoPdb Ligand ID: 9618

Synonyms: CC-220 | compound 6 [PMID: 28425720]
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Iberdomide (CC-220) is a novel cereblon modulator [3], functionally akin to lenalidomide and pomalidomide.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 88.18
Molecular weight 449.2
XLogP 1.36
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C1CCC(C(=O)N1)N1Cc2c(C1=O)cccc2OCc1ccc(cc1)CN1CCOCC1
Isomeric SMILES O=C1CC[C@@H](C(=O)N1)N1Cc2c(C1=O)cccc2OCc1ccc(cc1)CN1CCOCC1
InChI InChI=1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1
InChI Key IXZOHGPZAQLIBH-NRFANRHFSA-N
Immunopharmacology Comments
CC-220 is a novel cereblon-binding immunomodulator [3], functionally akin to lenalidomide and pomalidomide.
Immunopharmacology Disease
Disease X-Refs Comment References
Systemic lupus erythematosus Disease Ontology: DOID:9074
OMIM: 152700
Orphanet: ORPHA536
Phase 2 clinical candidate for SLE- see NCT03161483
Multiple myeloma Disease Ontology: DOID:9538
OMIM: 254500
Phase 1/2 clinical candidate for MM- see NCT03161483